Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 1751–1800 of 18397
Effective March 31, 2025, Mr. Kenneth W. Perry has been appointed to serve as Chief Financial Officer for the company
On March 31, 2025 and effective April 2, 2025 (the "Effective Date"), the Board of Directors (the “Board”) of Arq, Inc. (the “Company”) appointed Jay L. Voncannon, 59, as the Company’s Chief Financial Officer
Mr. Dutt’s employment with the Company ended on March 31, 2025.
Reginald Averilla who had served as the Company’s CFO since April 11, 2022, left the Company to pursue other opportunities.
On April 1, 2025, Scientific Industries, Inc. (the “Company”), announced that it has appointed Nicholas Lavacca as its Chief Financial Officer (“CFO”).
On March 31, 2025, David Lazar, the Company’s co-principal financial officer and co-principal accounting officer agreed to delay his previously announced resignation from March 31, 2025 until the date that the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2024 (the “Form 10-K”), is filed with the Securities and Exchange Commission (“SEC”). On such date, Mr. Lazar’s resignation shall be automatically effective.
Andrew F. Walters who was appointed to the position of Chief Executive Officer of the Company, also effective July 1, 2025.
On March 31, 2025, the Board of Directors of SJW Group (the "Company") appointed Ann P. Kelly, the Company's current Chief Accounting Officer and Principal Accounting Officer, to the position of Chief Financial Officer and Treasurer of the Company, effective July 1, 2025.
Thomas J. Edwards, Jr., 60, has been appointed Chief Operating Officer and Chief Financial Officer of Macy’s, Inc., effective June 22, 2025.
Adrian V. Mitchell, Chief Operating Officer and Chief Financial Officer, will be leaving the Company.
On April 1, 2025, FS Bancorp, Inc. (“Company”) (NASDAQ: FSBW), the holding company for 1st Security Bank of Washington (“1st Security Bank” or “Bank”) announced that it has named Phillip Whittington as Chief Financial Officer of both the Bank and the Company effective May 1, 2025.
Matthew D. Mullet the former Chief Financial Officer and President will continue to serve as President for both the Company and the Bank.
Dennis Norman was appointed as Vice President and Chief Financial Officer of the Company
Jonathan H. Baksht resigned as Chief Financial Officer, principal financial officer and principal accounting officer of the Company
Stanley Bikulege was appointed as President and Chief Executive Officer of the Company
Michael J. King resigned as President and Chief Executive Officer and principal executive officer of the Company
On March 31, 2025, TechPrecision Corporation (the “ Company ”) announced that the Board of Directors (the “ Board ”) of the Company appointed Phillip E. Podgorski to serve as the Chief Financial Officer of the Company, effective March 31, 2025
Barbara M. Lilley stepped down as the Company’s Interim Chief Financial Officer and will retain her position as Controller of Ranor, Inc., a wholly owned subsidiary of the Company, effective on the Transition Date.
On March 31, 2025, effective upon the completion of the Distribution and pursuant to the employment transition agreement previously filed by the Company on January 13, 2025 with the Securities Exchange Commission as Exhibit 10.1 to the Current Report on Form 8-K dated January 13, 2025, Joseph Levin ceased to serve as Chief Executive Officer of the Company and as a member of the board of directors of the Company.
Thomas M. O’Brien stepped down as Chairman, President and Chief Executive Officer
Terrie Curran who resigned as President and Chief Executive Officer and as a member of the Company’s Board of Directors (the “Board”) for personal reasons, effective March 31, 2025.
Steven Basta was appointed as the Chief Executive Officer, President and as a Class I director of Phathom Pharmaceuticals, Inc. (the “Company”), replacing Terrie Curran who resigned as President and Chief Executive Officer and as a member of the Company’s Board of Directors (the “Board”) for personal reasons, effective March 31, 2025.
On March 26, 2025, Abhishek Bawa notified the board of directors (the "Board") of ClimateRock (the "Company") of his resignation as Chief Financial Officer of the Company, effective on March 26, 2025.
First Northwest Bancorp ("First Northwest") and its wholly owned subsidiary First Fed Bank ("First Fed" and, together with First Northwest, the "Company") has announced that on March 27, 2025, Phyllis Nomura was appointed Executive Vice President and Chief Financial Officer / Treasurer of the Company, effective immediately.
On March 26, 2025, the board of directors of the Company (the “Board”) appointed Greg Lipschitz as the Chief Executive Officer of the Company.
On April 1, 2025 (the “ Effective Date ”), Universal Biosensors, Inc. (the “ Company ”) announced that John Sharman resigned from his position as Chief Executive Officer and Managing Director on the Board of Directors (the “ Board ”) of the Company, effective on the Effective Date.
On the Effective Date, the Company announced that the Board appointed Peter Mullin as Chief Executive Officer and Managing Director of the Board, effective as of the Effective Date.
The Company has appointed Rajal Mehta as Interim Chief Financial Officer effective upon Mr. Edwards’ departure.
On March 27, 2025, Thomas J. Edwards, Jr., Executive Vice President, Chief Financial Officer and Chief Operating Officer of Capri Holdings Limited (the “ Company ”) notified the Company of his decision to resign from his position, effective June 20, 2025, to pursue another opportunity.
James E. Hendricks, Jr., former President and Chief Executive Officer of Village, became a Senior Executive Vice President of TowneBank at the effective time of the Transaction.
The Board has appointed Carrie Lachance as the new CEO, effective as of the Separation Date.
Mr. DiIorio will step down as the Company's Chief Executive Officer ("CEO"), effective May 19, 2025
As a result of the passing of Pankaj Mohan, President, Chief Executive Officer and Chairman of the Board of Directors (the “Board”) of Sonnet BioTherapeutics Holdings, Inc. (the “Company”), on March 31, 2025, the Board unanimously appointed Raghu Rao, 62, a current member of the Board, as interim Chief Executive Officer and promoted Stephen McAndrew, Ph.D., the Company’s current Chief Business Officer, to President and Chief Business Officer.
the Board unanimously appointed Raghu Rao, 62, a current member of the Board, as interim Chief Executive Officer
appointed Ms. Robyn Liska as Interim Chief Financial Officer of the Company effective March 31, 2025.
Eric Williams stepped down as Executive Vice President, Chief Financial Officer of the Company effective March 30, 2025.
Mark Lappe will continue in his roles as Chief Executive Officer and Chairperson of the Board of Directors, but will no longer hold the title of President.
Effective April 1, 2025, Gregory S. Lovins, Senior Vice President and Chief Financial Officer of Avery Dennison Corporation (the “Company”), will resume serving as the Company’s principal financial officer following a previously disclosed medical leave of absence that began on November 14, 2024.
On March 28, 2025, Jennifer Gravelle, Vice President, Chief Financial Officer and Treasurer of Kingstone Companies, Inc. (the “Company”), advised the Company that she will be resigning from her positions for personal reasons to pursue other opportunities.
On March 31, 2025, the Board of Directors (the “Board”) of Jack in the Box Inc. (the “Company”) appointed Mr. Lance Tucker to serve as the Company’s Chief Executive Officer and as a member of the Board, effective immediately.
On March 5, 2025, Sleep Number Corporation (the “Company”) announced that the Board of Directors unanimously appointed Linda Findley to the position of President and Chief Executive Officer and Board member, effective as of April 7, 2025.
Mr. Repp will succeed James F. Brunk, 59, who has served as Chief Accounting Officer and Corporate Controller on an interim basis since March 14, 2025, while the Company conducted a search for a permanent replacement for the Company’s prior Chief Accounting Officer. Mr. Brunk will continue serving in his current role as Chief Financial Officer of the Company.
The Company also announced that effective July 1, 2025, Lara E. Ramsey, the President of the Company and the Bank, has been appointed by the Boards of Directors of the Company and the Bank to succeed Mr. Denardo as President and Chief Executive Officer of the Company and the Bank upon his retirement.
F. Brad Denardo, the Chief Executive Officer of the Company and the Company’s wholly owned banking subsidiary, The National Bank of Blacksburg (the “Bank”), will retire from such positions effective June 30, 2025.
A. Bradley Hill, the Company’s current President and Chief Investment Officer, will assume responsibilities as the Company’s Chief Executive Officer effective April 1, 2025
H. Eric Bolton, Jr. is retiring from his position as Chief Executive Officer of Mid-America Apartment Communities, Inc. (the “Company”) effective upon the end of business on March 31, 2025
the board of directors (the “Board”) of Encore Capital Group, Inc. (the “Company”) appointed Tomas Hernanz to succeed Jonathan Clark as Executive Vice President, Chief Financial Officer and Treasurer of the Company, effective April 1, 2025.
On March 25, 2025, Ward Morrison, President and CEO of Motto Mortgage and wemlo, subsidiaries of RE/MAX Holdings, Inc. (the “Company”), informed the Company of his intention to retire, effective June 15, 2025.
On March 26, 2025, David Gibbs, the Company’s Chief Executive Officer, informed the Board of Directors of his intention to retire in 2026.
the Board appointed Kathleen Valiasek, who currently serves as the Company’s Chief Financial Officer and President, as Chief Executive Officer of the Company, effective March 31, 2025.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.